Cannabis in Pain Management Seminar

Cannabis in Pain Management Seminar8:00 AM – 4:00 PM
Thursday, September 4, 2003
(as part of the)
American Academy of Pain Management
14th Annual Clinical Meeting
September 4-7, 2003

Adam’s Mark Hotel
1550 Court Place
Denver, CO 80202
(800) 444-2326

Dr. Ethan Russo, a child and adult neurologist in Missoula, Montana and Editor-in-Chief of the Journal of Cannabis Therapeutics, will be chairing an all-day seminar on Cannabis in Pain Management at the American Academy of Pain Management’s 14th Annual Clinical Meeting in Denver, Colorado on Thursday, September 4th, 2003. This seminar will give physicians the opportunity to learn more about the therapeutic value of medical cannabis, as well as hear leaders in the field of medical cannabis research describe and discuss their clinical findings. The following guest speakers will appear:

John McPartland: Dr. McPartland from Auckland, New Zealand, will present a general overview and discussion of endogenous cannabinoid pathways and anti-inflammatory mechanisms of cannabis.

Ken Mackie: Dr. Mackie, a professor of anesthesiology from the University of Washington, will present an intensive discussion of the interplay between endocannabinoid, endorphin and vanilloid mechanisms of pain control.

Philippe Lucas: Mr. Lucas from Victoria, BC will present his experiences running a “Compassion Club” on Vancouver Island, British Columbia, Canada that provides clinical cannabis to several hundred clients for a wide variety of conditions with different cannabis strains and delivery techniques.

David Hadorn: Dr. Hadorn from Berkeley, CA will present his views on how a physician can properly evaluate a patient for clinical cannabis and stay within state and federal law.

Ethan Russo: Dr. Russo from Missoula, MT will discuss cannabis’ history in pain, new pain indications, and the process of creating prescription cannabinoids. This will be an update and expansion of the 2002 talk with demonstration of a variety of delivery techniques.

Dr. Willy Notcutt (Great Yarmouth), Dr. Philip Robson (Oxford), and Dr. Geoffrey Guy (Chairman of GW Pharmaceuticals): A presentation of GW Pharmaceuticals Phase II and III clinical trial results in the United Kingdom using CBME (Cannabis-Based Medicine Extracts) including the neuropathic pain trial, the brachial plexus avulsion trial, and MS trials by their principle investigators. Time will be allotted for Q & A.

For more information about the Cannabis in Pain Management Seminar, please contact Dr. Ethan Russo at (406) 327-3372 or [email protected]. For more information about attending the conference, please visit the American Academy of Pain Management’s website at www.aapainmanage.org.

Comments